A detailed history of Perpetual LTD transactions in Becton Dickinson & CO stock. As of the latest transaction made, Perpetual LTD holds 892 shares of BDX stock, worth $203,813. This represents 0.0% of its overall portfolio holdings.

Number of Shares
892
Previous 873 2.18%
Holding current value
$203,813
Previous $204 Million 5.41%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

BUY
$221.47 - $242.41 $4,207 - $4,605
19 Added 2.18%
892 $215 Million
Q2 2024

Jul 30, 2024

SELL
$225.07 - $246.17 $4,726 - $5,169
-21 Reduced 2.35%
873 $204 Million
Q1 2024

Apr 09, 2024

BUY
$233.45 - $247.73 $208,704 - $221,470
894 New
894 $221 Million
Q3 2023

Oct 10, 2023

SELL
$254.9 - $283.59 $318,625 - $354,487
-1,250 Reduced 50.98%
1,202 $311 Million
Q2 2023

Jul 13, 2023

SELL
$238.39 - $265.32 $50,300 - $55,982
-211 Reduced 7.92%
2,452 $647 Million
Q1 2023

May 08, 2023

BUY
$229.71 - $259.35 $227,412 - $256,756
990 Added 59.18%
2,663 $659 Million
Q3 2020

Dec 08, 2020

BUY
$215.77 - $276.76 $123,636 - $158,583
573 Added 52.09%
1,673 $389,000
Q2 2020

Nov 18, 2020

SELL
$219.9 - $263.41 $1.46 Million - $1.75 Million
-6,640 Reduced 85.79%
1,100 $555,000
Q1 2020

Nov 18, 2020

BUY
$195.69 - $279.01 $1.3 Million - $1.85 Million
6,640 Added 603.64%
7,740 $4.75 Million
Q3 2019

Oct 10, 2019

BUY
$230.58 - $256.08 $253,638 - $281,688
1,100 New
1,100 $278,000
Q1 2019

May 06, 2019

SELL
$206.05 - $248.17 $267,865 - $322,621
-1,300 Closed
0 $0
Q3 2018

Oct 30, 2018

BUY
$233.07 - $256.0 $302,991 - $332,800
1,300 New
1,300 $339,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Perpetual LTD Portfolio

Follow Perpetual LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perpetual LTD, based on Form 13F filings with the SEC.

News

Stay updated on Perpetual LTD with notifications on news.